EXHIBIT 10.2
Confidential Materials omitted and filed separately with the Securities and
Exchange Commission. Asterisks denote omissions.
AMENDMENT NO. 2
TO
AGREEMENT
BY AND BETWEEN
XXXXX XX AND MILLENNIUM PHARMACEUTICALS, INC.
This is Amendment No. 2, dated as of December 1, 1999 ("Amendment No. 2"), to
the Agreement, dated as of September 22, 1998 (the "Agreement"), as amended by
and between Xxxxx XX, located at X-00000 Xxxxxxxxxx, Xxxxxxx and Millennium
Pharmaceuticals Inc., located at 00 Xxxxxx Xxxxxx, Xxxxxxxxx, XX 00000, XXX.
INTRODUCTION
The Parties have determined that it is in their mutual best interest to amend
the Agreement in the manner set forth below.
Accordingly, in accordance with Section 11.5 of the Agreement, the Parties agree
to amend the Agreement as follows:
Confidential Materials omitted and filed separately with the Securities and
Exchange Commission. Asterisks denote omissions.
-2-
1. EXHIBIT D
Exhibit D of the Agreement is hereby amended by deleting Exhibit D in
its entirety and by substituting the following in its place:
Program Payment Schedule
DATE PAYMENT DUE
February 1, 1999 $ [**]
May 1, 1999 $ [**]
August 1, 1999 $ [**]
November 1, 1999 $ [**]
December 1, 1999 $ [**]
February 1, 2000 $ [**]
May 1, 2000 $ [**]
August 1, 2000 $ [**]
November 1, 2000 $ [**]
February 1, 2001 $ [**]
May 1, 2001 $ [**]
August 1, 2001 $ [**]
November 1, 2001 $ [**]
February 1, 2002 $ [**]
May 1, 2002 $ [**]
August 1, 2002 $ [**]
November 1, 2002 $ [**]
February 1, 2003 $ [**]
May 1, 2003 $ [**]
August 1, 2003 $ [**]
- 3 -
2. GENERAL
In all other respects, the Agreement is hereby ratified and
confirmed.
IN WITNESS WHEREOF, the Parties have executed this Amendment No. 2 as
of the date set forth above.
XXXXX XX
By: /s/ XXXXX XXXXXXX
/s/ XX. XXXXXXXX XXXXXXXXXX
Title: PH-BPA Head
By: ____________________________
Title: ____________________________
MILLENNIUM PHARMACEUTICALS, INC.
By: /s/ XXXXXX X. XXXXXXXX
Title: Chief Business Officer
